Acorda Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Acorda Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2012 to Q4 2023.
  • Acorda Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $6.03M, a 3.4% decline year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $6.03M -$212K -3.4% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $6.24M -$133K -2.09% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $6.37M -$723K -10.2% Dec 31, 2021 10-K 2024-04-01
Q4 2020 $7.09M -$52K -0.73% Dec 31, 2020 10-K 2023-03-15
Q4 2019 $7.15M -$113K -1.56% Dec 31, 2019 10-K 2022-03-18
Q4 2018 $7.26M -$139K -1.88% Dec 31, 2018 10-K 2021-03-16
Q4 2017 $7.4M +$541K +7.89% Dec 31, 2017 10-K 2020-02-28
Q4 2016 $6.86M +$2.02M +41.8% Dec 31, 2016 10-K 2020-02-28
Q4 2015 $4.84M +$1.54M +46.7% Dec 31, 2015 10-K 2019-02-27
Q4 2014 $3.3M +$1.05M +46.8% Dec 31, 2014 10-K/A 2018-03-09
Q4 2013 $2.24M +$308K +15.9% Dec 31, 2013 10-K 2017-02-27
Q4 2012 $1.94M Dec 31, 2012 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.